Source: FirstWord Pharma

Mdcalc: Absolute Lymphocyte Count Is an Independent Survival Predictor in Patients With AML Treated With Intensive Chemotherapy

By Denise Baez VIRTUAL -- June 16, 2022 -- Absolute lymphocyte count (ALC) after intensive chemotherapy is a promising survival predictor in patients with acute myeloid leukaemia (AML), especially in ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Joe Habboushe's photo - Co-Founder & CEO of MDCalc

Co-Founder & CEO

Joe Habboushe

CEO Approval Rating

90/100

Read more